newsfilter
← Latest News
GlobeNewswire·

VERAXA Biotech Announces Regulatory Progress with its BiTAC®-TCE Development Plan

ZURICH, SWITZERLAND – July 20, 2026 – VERAXA Biotech AG (NASDAQ:VRXA, "VERAXA)), an emerging leader in designing novel cancer therapies, today announced that it has received Scientific Advice from the German